Yao-fei Pei

656 total citations
13 papers, 474 citations indexed

About

Yao-fei Pei is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yao-fei Pei has authored 13 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Surgery. Recurrent topics in Yao-fei Pei's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yao-fei Pei is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (4 papers) and Cancer-related molecular mechanisms research (4 papers). Yao-fei Pei collaborates with scholars based in China. Yao-fei Pei's co-authors include Xiqiang Liu, Xiqiang Liu, Yao Lei, Xiqiang Liu, Ran Tao, Ran Tao, Weiding Wu, Yajing Zhang, Bing Zhou and Tonghui Ma and has published in prestigious journals such as PLoS ONE, American Journal Of Pathology and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

In The Last Decade

Yao-fei Pei

13 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yao-fei Pei China	11	334	175	101	76	65	13	474
Pingsheng Fan China	12	354 1.1×	170 1.0×	130 1.3×	59 0.8×	41 0.6×	29	509
Shifeng Xu China	12	239 0.7×	177 1.0×	143 1.4×	109 1.4×	61 0.9×	22	456
Deguang Kong China	11	306 0.9×	151 0.9×	81 0.8×	152 2.0×	47 0.7×	13	502
Teruhide Ishigame Japan	12	197 0.6×	132 0.8×	141 1.4×	101 1.3×	61 0.9×	36	406
Ninghua Yao China	13	331 1.0×	266 1.5×	117 1.2×	79 1.0×	39 0.6×	43	516
Jun Zou China	9	301 0.9×	159 0.9×	84 0.8×	54 0.7×	40 0.6×	15	393
Nanhong Tang China	11	211 0.6×	173 1.0×	102 1.0×	40 0.5×	68 1.0×	18	391
Linjun Hu China	13	250 0.7×	211 1.2×	113 1.1×	89 1.2×	57 0.9×	28	482

Countries citing papers authored by Yao-fei Pei

Since Specialization

Citations

This map shows the geographic impact of Yao-fei Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao-fei Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao-fei Pei more than expected).

Fields of papers citing papers by Yao-fei Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao-fei Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao-fei Pei. The network helps show where Yao-fei Pei may publish in the future.

Co-authorship network of co-authors of Yao-fei Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Yao-fei Pei. A scholar is included among the top collaborators of Yao-fei Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao-fei Pei. Yao-fei Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Pei, Yao-fei, Bing Zhou, & Xiqiang Liu. (2022). The long non-coding RNA rhabdomyosarcoma 2-associated transcript exerts anti-tumor effects on lung adenocarcinoma via ubiquitination of SOX9. Annals of Translational Medicine. 10(1). 10–10. 8 indexed citations

Hua, Rong, Yao-fei Pei, Haiyong Gu, Yifeng Sun, & Yi He. (2021). Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway.. PubMed. 25(1). 262–267. 16 indexed citations

Pei, Yao-fei, et al.. (2020). The Crosstalk between lncRNA-SNHG7/miRNA-181/cbx7 Modulates Malignant Character in Lung Adenocarcinoma. American Journal Of Pathology. 190(6). 1343–1354. 24 indexed citations

Pei, Yao-fei, Xiangnan Xu, Fuwei Wang, et al.. (2019). Methyl-CpG Binding Domain Protein 2 Inhibits the Malignant Characteristic of Lung Adenocarcinoma through the Epigenetic Modulation of 10 to 11 Translocation 1 and miR-200s. American Journal Of Pathology. 189(5). 1065–1076. 9 indexed citations

Pei, Yao-fei, Jie Liu, Jian Cheng, Weiding Wu, & Xiqiang Liu. (2019). Silencing of LAMC2 Reverses Epithelial-Mesenchymal Transition and Inhibits Angiogenesis in Cholangiocarcinoma via Inactivation of the Epidermal Growth Factor Receptor Signaling Pathway. American Journal Of Pathology. 189(8). 1637–1653. 34 indexed citations

Pei, Yao-fei, et al.. (2017). TOP2A induces malignant character of pancreatic cancer through activating β-catenin signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(1). 197–207. 106 indexed citations

Pei, Yao-fei, et al.. (2017). Hypermethylation of the CHRDL1 promoter induces proliferation and metastasis by activating Akt and Erk in gastric cancer. Oncotarget. 8(14). 23155–23166. 41 indexed citations

Pei, Yao-fei, Yao Lei, & Xiqiang Liu. (2016). MiR-29a promotes cell proliferation and EMT in breast cancer by targeting ten eleven translocation 1. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1862(11). 2177–2185. 73 indexed citations

Pei, Yao-fei, Ran Tao, Jianfang Li, et al.. (2016). TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression. Oncotarget. 7(21). 31322–31335. 54 indexed citations

10.

Wang, Zhengting, Yao-fei Pei, Rong Fan, et al.. (2016). Inhibition of neddylation regulates dendritic cell functions via Deptor accumulation driven mTOR inactivation. Oncotarget. 7(24). 35643–35654. 22 indexed citations

11.

Chen, Mengmeng, Yilin Wang, Zhengting Wang, et al.. (2016). mTOR Inhibition Attenuates Dextran Sulfate Sodium-Induced Colitis by Suppressing T Cell Proliferation and Balancing TH1/TH17/Treg Profile. PLoS ONE. 11(4). e0154564–e0154564. 41 indexed citations

12.

Liu, Weiyan, et al.. (2014). Role of Liver in Modulating the Release of Inflammatory Cytokines Involved in Lung and Multiple Organ Dysfunction in Severe Acute Pancreatitis. Cell Biochemistry and Biophysics. 71(2). 765–776. 22 indexed citations

13.

Liu, Xiqiang, Zhiqiu Hu, Yao-fei Pei, & Ran Tao. (2013). Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects. Hepatobiliary & pancreatic diseases international. 12(1). 12–33. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pingsheng Fan Breakdown of academic impact, for papers by Shifeng Xu Breakdown of academic impact, for papers by Deguang Kong Breakdown of academic impact, for papers by Teruhide Ishigame Breakdown of academic impact, for papers by Ninghua Yao Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Nanhong Tang Breakdown of academic impact, for papers by Linjun Hu